OTCMKTS:PZRXQ

PhaseRx (PZRXQ) Stock Price, News & Analysis

$0.0002
0.00 (0.00%)
(As of 05/1/2024 ET)
Today's Range
$0.0002
$0.0002
50-Day Range
N/A
52-Week Range
$0.0001
$0.0003
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About PhaseRx

PhaseRx, Inc., a biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. The company develops its products based on its proprietary Hybrid mRNA technology platform, which allows the synthesis of missing enzyme inside the cell. Its therapeutic urea cycle disorder programs under development include PRX-OTC to treat ornithine transcarbamylase deficiency; PRX-ASL to treat argininosuccinate lyase deficiency; and PRX-ASS1 to treat argininosuccinate synthetase deficiency. The company was incorporated in 2006 and is headquartered in Seattle, Washington.

PZRXQ Stock Price History

PZRXQ Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive PZRXQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PhaseRx and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:PZRXQ
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.28
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Robert W. Overell Ph.D. (Age 68)
    Co-Founder, CEO, President, Principal Accounting Officer, Secretary & Director
    Comp: $487.17k
  • Dr. Paul H. Johnson Ph.D. (Age 81)
    Co-Founder & Director
    Comp: $33.12k
  • Prof. Allan S. Hoffman
    Co-Founder
  • Dr. Patrick S. Stayton Ph.D.
    Co-Founder
  • Dr. Oliver W. Press M.D.
    Ph.D., Co-Founder

PZRXQ Stock Analysis - Frequently Asked Questions

How have PZRXQ shares performed in 2024?

PhaseRx's stock was trading at $0.0002 at the start of the year. Since then, PZRXQ stock has increased by 0.0% and is now trading at $0.0002.
View the best growth stocks for 2024 here
.

How do I buy shares of PhaseRx?

Shares of PZRXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PZRXQ) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners